

Abcam, which markets antibodies via its own online catalogue, said profit before tax will be around 9% higher than expectations as sales rose on the b...


Broker comments in the UK today. Compiled by Dow Jones Newswires Markets Desk, markets.eu@dowjones.com Contact us in London. +44-20-7842-9464 Markett...


1328 GMT [Dow Jones] KBC Peel Hunt raises Abcam (ABC.LN) price target to 1400p from 1320p. It expects a positive FY'10 statement in July, based on str...


Non-executive director John May has acquired his first shares in corporate recovery firm Begbies Traynor since joining the board in October 2007. Ma...


Professor Tony Kouzarides, a co-founder of online catalogue-based antibodies distributor Abcam, has sold more than one-quarter of his shareholding. ...


As one analyst said last week, "at last BP has bought a ticket to the carnival". The carnival he was referring to was, of course Brazilian oil. Most o...


The second half of 2009 was a period of expansion for catalogue-based antibodies distributor Abcam wich increased the size of its catalogue, boosted ...


Croda International chief executive Michael Humphrey has taken up 109,300 shares via the senior executive option scheme and then sold most of them at ...